Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor.

Published

Journal Article

Oxidative stress suppresses host immunity by generating oxidized lipid agonists of the platelet-activating factor receptor (PAF-R). Because many classical chemotherapeutic drugs induce reactive oxygen species (ROS), we investigated whether these drugs might subvert host immunity by activating PAF-R. Here, we show that PAF-R agonists are produced in melanoma cells by chemotherapy that is administered in vitro, in vivo, or in human subjects. Structural characterization of the PAF-R agonists induced revealed multiple oxidized glycerophosphocholines that are generated nonenzymatically. In a murine model of melanoma, chemotherapeutic administration could augment tumor growth by a PAF-R-dependent process that could be blocked by treatment with antioxidants or COX-2 inhibitors or by depletion of regulatory T cells. Our findings reveal how PAF-R agonists induced by chemotherapy treatment can promote treatment failure. Furthermore, they offer new insights into how to improve the efficacy of chemotherapy by blocking its heretofore unknown impact on PAF-R activation.

Full Text

Duke Authors

Cited Authors

  • Sahu, RP; Ocana, JA; Harrison, KA; Ferracini, M; Touloukian, CE; Al-Hassani, M; Sun, L; Loesch, M; Murphy, RC; Althouse, SK; Perkins, SM; Speicher, PJ; Tyler, DS; Konger, RL; Travers, JB

Published Date

  • December 2014

Published In

Volume / Issue

  • 74 / 23

Start / End Page

  • 7069 - 7078

PubMed ID

  • 25304264

Pubmed Central ID

  • 25304264

Electronic International Standard Serial Number (EISSN)

  • 1538-7445

International Standard Serial Number (ISSN)

  • 0008-5472

Digital Object Identifier (DOI)

  • 10.1158/0008-5472.CAN-14-2043

Language

  • eng